Phase I, Pharmacokinetic, and Biological Study of Erlotinib in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-1886
Full Text
Open PDFAbstract
Available in full text
Date
December 15, 2006
Authors
Publisher
American Association for Cancer Research (AACR)